The active principles inherent in the technology associated with our agricultural products, relate to the effects obtained by delivering to the plant cell a complex of 19 free biologically active amino-acids denoted as SFAAs (synthesized free amino-acids), along with shorts chains of up to three amino-acids denoted as LWOPs (low molecular weight oligo-peptides). Each of our products namely BIOKAD, BIOFOS and BIOHUMEis characterized by combining the same complex with different macro and micro elements specific to the plant’s requirement at different stages of its development. In the case of BIOAMINOL, the product is just the complex without any other micro elements. All these products have a quick absorption (90% within 7 hours of foliar application).
Essentially, the amino-acids and oligo-peptides permit the plant to achieve an optimal metabolism by delivering to its cells a full set of the necessary molecular elements required for the realization of fundamental metabolic functions. More specifically, it has been shown to increase m-RNA synthesis, in the cells of legumes, wheat and cereals between 130%-330% (Kvesitadzeet col). Also it has been reported to increase m-RNA synthesis and subsequently neuropeptide secretion in rat embrionneuroblasts (Sanchez, Franco et col). These increases in m-RNA synthesis provide a substantial overall energy savings to the cell. Recent findings in molecular genetics show that low molecular weight peptides play fundamental roles in the rate of m-RNA synthesis, which in turn permit a corresponding increase in the cell’s ability to synthesize proteins. Thus perhaps in a similar way, the SFAAs and LWOPs stimulate or enhance the plant’s natural capacity to produce its own hormones, enzymes and other amino-acids based cell products.
The industrial process of developing these amino acids is based on solid state chemistry, HPLC chromatography, electronic technology and special software, allows the synthesis of these L-aminoacids to be reproduced on an industrial scale, always in identical quantities, free from impurities and, what is the most important, oligopeptides of 2, 3 and 4 aminoacids to be synthesized, always with the same amino acids sequence and molecular structure, which gives them identical characteristics as the cellular Transcription Factors, that is to say, industrial production of biologically active Extra cellular Transcription Factors (ETF) to be achieved.
The Japanese and other manufacturers are selling huge amounts of amino acids obtained via fermentation or hydrolysis.